Kerry Wentworth, CHIEF REGULATORY OFFICER at Nuvation Bio Inc. (NUVB), sold 63,000 shares at $6.02 ($379K) on 2026-06-23, disclosed to the SEC on 2026-06-24.
Scheduled sale ($379k) by CHIEF REGULATORY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $152K | — | Filing → |